BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16302561)

  • 1. Bullous pemphigoid following therapy with an oral beta-blocker.
    Perry A; Sparling JD; Pennington M
    J Drugs Dermatol; 2005; 4(6):746-8. PubMed ID: 16302561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.
    Sakanoue M; Kawai K; Kanekura T
    J Dermatol; 2012 Oct; 39(10):884-5. PubMed ID: 22168231
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
    Ratnam KV
    Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].
    Elser I; Selimovic D; Ruzicka T; Kuhn A; Megahed M
    Hautarzt; 2003 Oct; 54(10):981-4. PubMed ID: 14513249
    [No Abstract]   [Full Text] [Related]  

  • 6. A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis.
    Wang G; Hu X; Han S; Zhou M
    J Dermatolog Treat; 2024 Dec; 35(1):2366535. PubMed ID: 38945532
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid.
    Paul MA; Jorizzo JL; Fleischer AB; White WL
    J Am Acad Dermatol; 1994 Oct; 31(4):620-5. PubMed ID: 8089289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy.
    Fox JC; Kenkare S; Petronic-Rosic V; Soltani K; Sethi A
    Pediatr Dermatol; 2010; 27(5):537-9. PubMed ID: 20807355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullous pemphigoid in adolescence, a rare demographic.
    Brown H; Lamrock E; Jenkins D
    Australas J Dermatol; 2021 Feb; 62(1):e95-e97. PubMed ID: 32935855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid induced by contact with a Rhus tree.
    Lee HM; Cho YH; Koo DW; Lee JS
    Eur J Dermatol; 2012; 22(5):683-4. PubMed ID: 22759593
    [No Abstract]   [Full Text] [Related]  

  • 11. Localized bullous pemphigoid in a patient with primary lymphoedema tarda.
    Perez A; Clements SE; Benton E; Robson A; Bhogal B; Stefanato CM; McGibbon D
    Clin Exp Dermatol; 2009 Dec; 34(8):e931-3. PubMed ID: 20055870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful therapy for bullous pemphigoid with mycophenolate mofetil.
    Nousari HC; Griffin WA; Anhalt GJ
    J Am Acad Dermatol; 1998 Sep; 39(3):497-8. PubMed ID: 9738791
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.
    Heilborn JD; Ståhle-Bäckdahl M; Albertioni F; Vassilaki I; Peterson C; Stephansson E
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):741-9. PubMed ID: 10321603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
    Seminario-Vidal L; Sami N; Miller J; Theos A
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
    Czernik A; Bystryn JC
    Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
    Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
    N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furosemide-induced bullous pemphigoid: case report and review of literature.
    Lee JJ; Downham TF
    J Drugs Dermatol; 2006 Jun; 5(6):562-4. PubMed ID: 16774111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid treated with mycophenolate mofetil.
    Böhm M; Beissert S; Schwarz T; Metze D; Luger T
    Lancet; 1997 Feb; 349(9051):541. PubMed ID: 9048797
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non necrotizing bacterial cellulitis and bacteriemia due to Shewanella putrefaciens].
    Aubert T; Rovery C; Bourhaba K; Singeorzan S; Heim M; Crétel E
    Rev Med Interne; 2009 Sep; 30(9):800-2. PubMed ID: 19282070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.